Swetha Krishnan on her journey from Individual Contributor to Inspiring People Leader

She came to the US with her first year's tuition and figured the rest out from there. What followed is one of the most grounded quality leadership journeys I have heard - and one we felt was worth bringing back.Swetha Krishnan on Building a Quality Mindset from the Ground UpThis is a rerelease of one of our favourite episodes from two years ago. In today's episode I was joined by Swetha Krishnan. I really wanted to bring this conversation back because Swetha's route into quality was entirely unplanned - and the way she has turned that unplanned start into a clear leadership philosophy is something every quality professional should hear.Swetha came to the US from India to complete a master’s in bioengineering at the University of Toledo. She needed work, she needed a visa sponsor, and she found her way into a contractor role at Pfizer in Connecticut doing technical writing and validation. It was not the destination she had mapped out, but two years of being moved from role to role - quality management systems, regulatory content authoring, client-facing support - gave her a cross-functional view of how a pharma company actually operates. From there she moved through roles at Biogen, Sanofi Genzyme, and Alkermes before taking on her current position leading quality across all GXPs at Mural Oncology, a clinical-stage biotech focused on cytokine-based immunotherapies for cancer.Swetha leads with a combination of strategic clarity and genuine warmth. She is honest about the things she struggled with early on - particularly the belief that credibility required having all the answers - and equally clear about what changed that. She talks about the boss at Alkermes who told her she would one day be head of quality before she believed it herself, the nine-month Women Unlimited LEAD program that gave her two external mentors, and the MIT LeadershipSignature course that asked her to examine what in her personal history shapes how she shows up every day.We talk about the following:• How a bioengineering thesis on non-invasive glucose measurement for diabetics led to an unexpected start in quality• Starting as a contractor at Pfizer and what wearing so many hats in two years taught her about the whole product life cycle• Why validation gave her a quality mindset before she had ever formally joined a quality team• The shift from individual contributor to manager to leader of teams - and why it forced her to rethink everything she thought she knew about credibility• The nine-month Women Unlimited LEAD program at Alkermes and the boss who saw her potential before she saw it herself• Quality by design in practice - being involved in CRO selection from the start, not after the contract is signed• How she manages prioritisation, managing up, and keeping her team grounded in a lean, fast-moving clinical-stage biotech• Her 4C model for aspiring quality leaders: challenge, curiosity, collaboration, and compassionSwetha is a thoughtful, pragmatic quality leader who understands how to balance compliance, collaboration and business reality in complex development environments. If you are a quality professional working in an early-stage biotech and trying to build the right systems with limited resources, then this episode is for you. You can watch on LinkedIn Live at 12pm EST today or listen via Apple or Spotify. Thank you Swetha for sharing your incredible journey. Hope everyone enjoys the show.Who This Episode Is For• Quality managers and directors in clinical-stage biotech who are building systems and leading teams without large headcounts or unlimited budgets• Aspiring heads of quality who are in the transition from individual contributor to people leader and finding that shift harder than they expected• Quality professionals who came into the function from validation, technical writing, or another non-traditional route and are still making sense of how it all connects• Senior quality leaders who want a practical framework for developing the next generation on their team• Anyone in pharma or biotech who has ever felt like asking for help put their credibility at risk